Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-01-01

AUTHORS

Francisco Garcia Soriano, László Virág, Prakash Jagtap, Éva Szabó, Jon G. Mabley, Lucas Liaudet, Anita Marton, Dale G. Hoyt, Kanneganti G. K. Murthy, Andrew L. Salzman, Garry J. Southan, Csaba Szabó

ABSTRACT

Diabetic patients frequently suffer from retinopathy, nephropathy, neuropathy and accelerated atherosclerosis. The loss of endothelial function precedes these vascular alterations. Here we report that activation of poly(ADP-ribose) polymerase (PARP) is an important factor in the pathogenesis of endothelial dysfunction in diabetes. Destruction of islet cells with streptozotocin in mice induced hyperglycemia, intravascular oxidant production, DNA strand breakage, PARP activation and a selective loss of endothelium-dependent vasodilation. Treatment with a novel potent PARP inhibitor, starting after the time of islet destruction, maintained normal vascular responsiveness, despite the persistence of severe hyperglycemia. Endothelial cells incubated in high glucose exhibited production of reactive nitrogen and oxygen species, consequent single-strand DNA breakage, PARP activation and associated metabolic and functional impairment. Basal and high-glucose-induced nuclear factor-κB activation were suppressed in the PARP-deficient cells. Our results indicate that PARP may be a novel drug target for the therapy of diabetic endothelial dysfunction. More... »

PAGES

108-113

Journal

TITLE

Nature Medicine

ISSUE

1

VOLUME

7

Related Patents

  • Poly (Adp-Ribose) Synthetase Inhibitors; Synergistic; Indeno[1,2-C]Isoquinoline Derivatives; Inflammatory Disease, A Reperfusion Injury, Diabetes Or Its Complications, Reoxygenation Injury Resulting From Organ Transplantation, An Ischemic Condition, Parkinson's Disease, Renal Failure, A Vascular Disease
  • Indenoisoquinolinone Analogs And Methods Of Use Thereof
  • Synthesis And Use Of Tetracyclic Benzamide Derivatives; Antidiabetic Agents; Coupling Isochromene Anhydride With Cyanobenzene Compound And Performing Ring Substitution Reactions
  • Isoquinoline Derivatives And Methods Of Use Thereof
  • Antiinflamamtory Agents; Strokes; Cardiovascular Disorders
  • Nitrogen Compounds Such As 5,6-Dihydro-5,11-Diketo-11h-Indeno (1,2-C)Isoquinoline, Used As Poly/Adp-Ribose/ Synthase Inhibitors In Cells, And For Prophylaxis Of Reperfusion Injuries, Diabetes Or Inflammation
  • Methods Of Treating Mitochondrial Dysfunction
  • Monitoring Of The Inhibition Of Fatty Acid Synthesis By Iodo-Nitrobenzamide Compounds
  • Poly/Adp-Ribose/Polymerase Inhibitors (Parp); Administering 4-Iodo-3-Nitrobenzamide, Gemcitabine, And Carboplatin; Gene Therapy
  • Methods Of Treating Mitochondrial Dysfunction
  • Poly(Adp-Ribose) Polymerase (Parp) Inhibitors Such As 9-Hydroxythieno[2,3-C]Isoquin-5(4h)-One, Used For Treating Tumor Diseases, Leukaemia, Sarcoma, Tissue Damage Due To Ischemia And Reperfusion, Inflammatory Disease, Retinal Ischemia Or Brain Trauma
  • Treatment Of Cancer
  • Niacinamide (Nam) In Ischemic Tissue Injury
  • Treatment Of Cancer
  • For Therapy And Prophylaxis Of Inflammatory Disease, A Reperfusion Disease, An Ischemic Condition, Renal Failure, Diabetes, A Diabetic Complication, A Vascular Disease, Or Cancer
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/83241

    DOI

    http://dx.doi.org/10.1038/83241

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1045537529

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/11135624


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Diabetes Mellitus, Experimental", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Endothelium, Vascular", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Enzyme Activation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glucose", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunohistochemistry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "In Vitro Techniques", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "NF-kappa B", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Poly(ADP-ribose) Polymerases", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Critical Care Medicine, Hospital das Clinicas da Universidade de Sao Paulo, Sao Paulo, Brazil", 
              "id": "http://www.grid.ac/institutes/grid.411074.7", 
              "name": [
                "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA", 
                "Department of Surgery, New Jersey Medical School, University of Medicine and Dentistry New Jersey, 185 University Heights, 01703, Newark, New Jersey, USA", 
                "Department of Critical Care Medicine, Hospital das Clinicas da Universidade de Sao Paulo, Sao Paulo, Brazil"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Garcia Soriano", 
            "givenName": "Francisco", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.284589.a", 
              "name": [
                "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Vir\u00e1g", 
            "givenName": "L\u00e1szl\u00f3", 
            "id": "sg:person.01060330541.04", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060330541.04"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.284589.a", 
              "name": [
                "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Jagtap", 
            "givenName": "Prakash", 
            "id": "sg:person.01271463624.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271463624.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.284589.a", 
              "name": [
                "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Szab\u00f3", 
            "givenName": "\u00c9va", 
            "id": "sg:person.01216344363.14", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216344363.14"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.284589.a", 
              "name": [
                "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mabley", 
            "givenName": "Jon G.", 
            "id": "sg:person.015467071427.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015467071427.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Internal Medicine, Critical Care Division, University Hospital, Lausanne, Switzerland", 
              "id": "http://www.grid.ac/institutes/grid.8515.9", 
              "name": [
                "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA", 
                "Department of Surgery, New Jersey Medical School, University of Medicine and Dentistry New Jersey, 185 University Heights, 01703, Newark, New Jersey, USA", 
                "Department of Internal Medicine, Critical Care Division, University Hospital, Lausanne, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Liaudet", 
            "givenName": "Lucas", 
            "id": "sg:person.0675766741.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675766741.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.284589.a", 
              "name": [
                "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Marton", 
            "givenName": "Anita", 
            "id": "sg:person.01174557141.43", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174557141.43"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Pharmacology, College of Pharmacy, The Ohio State University, 496 West 12th Avenue, 43210, Columbus, Ohio, USA", 
              "id": "http://www.grid.ac/institutes/grid.261331.4", 
              "name": [
                "Division of Pharmacology, College of Pharmacy, The Ohio State University, 496 West 12th Avenue, 43210, Columbus, Ohio, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hoyt", 
            "givenName": "Dale G.", 
            "id": "sg:person.01242743756.91", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242743756.91"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.284589.a", 
              "name": [
                "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Murthy", 
            "givenName": "Kanneganti G. K.", 
            "id": "sg:person.012766442042.28", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012766442042.28"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.284589.a", 
              "name": [
                "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Salzman", 
            "givenName": "Andrew L.", 
            "id": "sg:person.0676312677.21", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676312677.21"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.284589.a", 
              "name": [
                "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Southan", 
            "givenName": "Garry J.", 
            "id": "sg:person.010261433767.86", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010261433767.86"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, New Jersey Medical School, University of Medicine and Dentistry New Jersey, 185 University Heights, 01703, Newark, New Jersey, USA", 
              "id": "http://www.grid.ac/institutes/grid.430387.b", 
              "name": [
                "Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA", 
                "Department of Surgery, New Jersey Medical School, University of Medicine and Dentistry New Jersey, 185 University Heights, 01703, Newark, New Jersey, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Szab\u00f3", 
            "givenName": "Csaba", 
            "id": "sg:person.0663715027.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663715027.63"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/35008121", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031794389", 
              "https://doi.org/10.1038/35008121"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/34923", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004282327", 
              "https://doi.org/10.1038/34923"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/6535", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006268292", 
              "https://doi.org/10.1038/6535"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm1097-1089", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052495095", 
              "https://doi.org/10.1038/nm1097-1089"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2001-01-01", 
        "datePublishedReg": "2001-01-01", 
        "description": "Diabetic patients frequently suffer from retinopathy, nephropathy, neuropathy and accelerated atherosclerosis. The loss of endothelial function precedes these vascular alterations. Here we report that activation of poly(ADP-ribose) polymerase (PARP) is an important factor in the pathogenesis of endothelial dysfunction in diabetes. Destruction of islet cells with streptozotocin in mice induced hyperglycemia, intravascular oxidant production, DNA strand breakage, PARP activation and a selective loss of endothelium-dependent vasodilation. Treatment with a novel potent PARP inhibitor, starting after the time of islet destruction, maintained normal vascular responsiveness, despite the persistence of severe hyperglycemia. Endothelial cells incubated in high glucose exhibited production of reactive nitrogen and oxygen species, consequent single-strand DNA breakage, PARP activation and associated metabolic and functional impairment. Basal and high-glucose-induced nuclear factor-\u03baB activation were suppressed in the PARP-deficient cells. Our results indicate that PARP may be a novel drug target for the therapy of diabetic endothelial dysfunction.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/83241", 
        "isAccessibleForFree": false, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2516501", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2613508", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1113716", 
            "issn": [
              "1078-8956", 
              "1546-170X"
            ], 
            "name": "Nature Medicine", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "7"
          }
        ], 
        "keywords": [
          "endothelial dysfunction", 
          "PARP activation", 
          "nuclear factor-\u03baB activation", 
          "normal vascular responsiveness", 
          "endothelium-dependent vasodilation", 
          "diabetic endothelial dysfunction", 
          "potent PARP inhibitor", 
          "vascular responsiveness", 
          "islet destruction", 
          "diabetic patients", 
          "endothelial function", 
          "vascular alterations", 
          "single-strand DNA breakage", 
          "severe hyperglycemia", 
          "novel drug targets", 
          "functional impairment", 
          "PARP-deficient cells", 
          "high glucose", 
          "islet cells", 
          "PARP inhibitors", 
          "polymerase activation", 
          "DNA strand breakage", 
          "endothelial cells", 
          "selective loss", 
          "oxidant production", 
          "hyperglycemia", 
          "dysfunction", 
          "activation", 
          "drug targets", 
          "oxygen species", 
          "strand breakage", 
          "cells", 
          "streptozotocin", 
          "vasodilation", 
          "retinopathy", 
          "patients", 
          "atherosclerosis", 
          "diabetes", 
          "DNA breakage", 
          "pathogenesis", 
          "therapy", 
          "mice", 
          "impairment", 
          "treatment", 
          "destruction", 
          "responsiveness", 
          "inhibitors", 
          "PARP", 
          "alterations", 
          "glucose", 
          "loss", 
          "important factor", 
          "target", 
          "factors", 
          "role", 
          "persistence", 
          "production", 
          "function", 
          "breakage", 
          "polymerase", 
          "time", 
          "results", 
          "reactive nitrogen", 
          "species", 
          "nitrogen"
        ], 
        "name": "Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation", 
        "pagination": "108-113", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1045537529"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/83241"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "11135624"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/83241", 
          "https://app.dimensions.ai/details/publication/pub.1045537529"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:49", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_311.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/83241"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/83241'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/83241'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/83241'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/83241'


     

    This table displays all metadata directly associated to this object as RDF triples.

    279 TRIPLES      21 PREDICATES      104 URIs      92 LITERALS      17 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/83241 schema:about N0ad995ac2ae246ef9bfb386528bd684d
    2 N6e24819db4dd4c36b028466e19c3641e
    3 N97b576c2b31846ee9dd982f6ac4aa056
    4 Nb7744af0674944d08154e77227a78f07
    5 Nc6c1ce3129a640f4813741dec016b3ce
    6 Ndb096ceb52844dfc9b9c034664be59fd
    7 Ndeebd7c168b842a29e866429fe4a03ea
    8 Ne83de13aa9a24f8f8d6eaab3d93a15c2
    9 Nf69a2afdba0e4add8b272e815cca8cd4
    10 Nfadab57d296e433b8d146abfa1c613a6
    11 anzsrc-for:11
    12 anzsrc-for:1103
    13 schema:author N0609980994d04b48946c1a80b63b5bf8
    14 schema:citation sg:pub.10.1038/34923
    15 sg:pub.10.1038/35008121
    16 sg:pub.10.1038/6535
    17 sg:pub.10.1038/nm1097-1089
    18 schema:datePublished 2001-01-01
    19 schema:datePublishedReg 2001-01-01
    20 schema:description Diabetic patients frequently suffer from retinopathy, nephropathy, neuropathy and accelerated atherosclerosis. The loss of endothelial function precedes these vascular alterations. Here we report that activation of poly(ADP-ribose) polymerase (PARP) is an important factor in the pathogenesis of endothelial dysfunction in diabetes. Destruction of islet cells with streptozotocin in mice induced hyperglycemia, intravascular oxidant production, DNA strand breakage, PARP activation and a selective loss of endothelium-dependent vasodilation. Treatment with a novel potent PARP inhibitor, starting after the time of islet destruction, maintained normal vascular responsiveness, despite the persistence of severe hyperglycemia. Endothelial cells incubated in high glucose exhibited production of reactive nitrogen and oxygen species, consequent single-strand DNA breakage, PARP activation and associated metabolic and functional impairment. Basal and high-glucose-induced nuclear factor-κB activation were suppressed in the PARP-deficient cells. Our results indicate that PARP may be a novel drug target for the therapy of diabetic endothelial dysfunction.
    21 schema:genre article
    22 schema:isAccessibleForFree false
    23 schema:isPartOf N026bb3ffb371442e8393932eaded5619
    24 N2c01ec96a66140279c6d0760dbaa8ad7
    25 sg:journal.1113716
    26 schema:keywords DNA breakage
    27 DNA strand breakage
    28 PARP
    29 PARP activation
    30 PARP inhibitors
    31 PARP-deficient cells
    32 activation
    33 alterations
    34 atherosclerosis
    35 breakage
    36 cells
    37 destruction
    38 diabetes
    39 diabetic endothelial dysfunction
    40 diabetic patients
    41 drug targets
    42 dysfunction
    43 endothelial cells
    44 endothelial dysfunction
    45 endothelial function
    46 endothelium-dependent vasodilation
    47 factors
    48 function
    49 functional impairment
    50 glucose
    51 high glucose
    52 hyperglycemia
    53 impairment
    54 important factor
    55 inhibitors
    56 islet cells
    57 islet destruction
    58 loss
    59 mice
    60 nitrogen
    61 normal vascular responsiveness
    62 novel drug targets
    63 nuclear factor-κB activation
    64 oxidant production
    65 oxygen species
    66 pathogenesis
    67 patients
    68 persistence
    69 polymerase
    70 polymerase activation
    71 potent PARP inhibitor
    72 production
    73 reactive nitrogen
    74 responsiveness
    75 results
    76 retinopathy
    77 role
    78 selective loss
    79 severe hyperglycemia
    80 single-strand DNA breakage
    81 species
    82 strand breakage
    83 streptozotocin
    84 target
    85 therapy
    86 time
    87 treatment
    88 vascular alterations
    89 vascular responsiveness
    90 vasodilation
    91 schema:name Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation
    92 schema:pagination 108-113
    93 schema:productId N0d3c8ef2463b424788ca81fc72a9afe0
    94 N0ead256121e9486dbabbec88123ffaab
    95 N605f30cc0afe4422817a84b46b8041bf
    96 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045537529
    97 https://doi.org/10.1038/83241
    98 schema:sdDatePublished 2022-11-24T20:49
    99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    100 schema:sdPublisher N2605d38cdd74442991eb3d54f4c79ea3
    101 schema:url https://doi.org/10.1038/83241
    102 sgo:license sg:explorer/license/
    103 sgo:sdDataset articles
    104 rdf:type schema:ScholarlyArticle
    105 N026bb3ffb371442e8393932eaded5619 schema:issueNumber 1
    106 rdf:type schema:PublicationIssue
    107 N0609980994d04b48946c1a80b63b5bf8 rdf:first Nf07c023fc2574cc096574901684fd0ae
    108 rdf:rest Nbf2bd9f62f0d46bca1f2f1f03a3659d7
    109 N0ad995ac2ae246ef9bfb386528bd684d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Diabetes Mellitus, Experimental
    111 rdf:type schema:DefinedTerm
    112 N0d3c8ef2463b424788ca81fc72a9afe0 schema:name doi
    113 schema:value 10.1038/83241
    114 rdf:type schema:PropertyValue
    115 N0ead256121e9486dbabbec88123ffaab schema:name dimensions_id
    116 schema:value pub.1045537529
    117 rdf:type schema:PropertyValue
    118 N2605d38cdd74442991eb3d54f4c79ea3 schema:name Springer Nature - SN SciGraph project
    119 rdf:type schema:Organization
    120 N28de321f16304dfc93eb908e9c819151 rdf:first sg:person.0676312677.21
    121 rdf:rest N7698a38a7890478b90d90cda1b5a2123
    122 N2c01ec96a66140279c6d0760dbaa8ad7 schema:volumeNumber 7
    123 rdf:type schema:PublicationVolume
    124 N4820b334582b49f083c3033310beac6c rdf:first sg:person.015467071427.47
    125 rdf:rest Ndc66eb27489a4bbd816baa763389c01f
    126 N50cd7e08b03940918ec715da1438c0ba rdf:first sg:person.01271463624.22
    127 rdf:rest N8dde5e1d96fd4737a88fefc0d6b46c6e
    128 N605f30cc0afe4422817a84b46b8041bf schema:name pubmed_id
    129 schema:value 11135624
    130 rdf:type schema:PropertyValue
    131 N6e24819db4dd4c36b028466e19c3641e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name NF-kappa B
    133 rdf:type schema:DefinedTerm
    134 N7698a38a7890478b90d90cda1b5a2123 rdf:first sg:person.010261433767.86
    135 rdf:rest Neb50d8bf16a24590a002e3f286a411ac
    136 N8dde5e1d96fd4737a88fefc0d6b46c6e rdf:first sg:person.01216344363.14
    137 rdf:rest N4820b334582b49f083c3033310beac6c
    138 N97b576c2b31846ee9dd982f6ac4aa056 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name Immunohistochemistry
    140 rdf:type schema:DefinedTerm
    141 Nb7744af0674944d08154e77227a78f07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Glucose
    143 rdf:type schema:DefinedTerm
    144 Nbf2bd9f62f0d46bca1f2f1f03a3659d7 rdf:first sg:person.01060330541.04
    145 rdf:rest N50cd7e08b03940918ec715da1438c0ba
    146 Nc6c1ce3129a640f4813741dec016b3ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Mice
    148 rdf:type schema:DefinedTerm
    149 Ndb096ceb52844dfc9b9c034664be59fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Animals
    151 rdf:type schema:DefinedTerm
    152 Ndc66eb27489a4bbd816baa763389c01f rdf:first sg:person.0675766741.07
    153 rdf:rest Nf1359b7d37af4e0b8b96e640b76439fb
    154 Ndeebd7c168b842a29e866429fe4a03ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Poly(ADP-ribose) Polymerases
    156 rdf:type schema:DefinedTerm
    157 Ne5bf16fc16e54b91845c8f21d5337554 rdf:first sg:person.012766442042.28
    158 rdf:rest N28de321f16304dfc93eb908e9c819151
    159 Ne83de13aa9a24f8f8d6eaab3d93a15c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name In Vitro Techniques
    161 rdf:type schema:DefinedTerm
    162 Neb50d8bf16a24590a002e3f286a411ac rdf:first sg:person.0663715027.63
    163 rdf:rest rdf:nil
    164 Nee3a3635fb014c299f670432ab1df8fe rdf:first sg:person.01242743756.91
    165 rdf:rest Ne5bf16fc16e54b91845c8f21d5337554
    166 Nf07c023fc2574cc096574901684fd0ae schema:affiliation grid-institutes:grid.411074.7
    167 schema:familyName Garcia Soriano
    168 schema:givenName Francisco
    169 rdf:type schema:Person
    170 Nf1359b7d37af4e0b8b96e640b76439fb rdf:first sg:person.01174557141.43
    171 rdf:rest Nee3a3635fb014c299f670432ab1df8fe
    172 Nf69a2afdba0e4add8b272e815cca8cd4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Endothelium, Vascular
    174 rdf:type schema:DefinedTerm
    175 Nfadab57d296e433b8d146abfa1c613a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Enzyme Activation
    177 rdf:type schema:DefinedTerm
    178 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    179 schema:name Medical and Health Sciences
    180 rdf:type schema:DefinedTerm
    181 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    182 schema:name Clinical Sciences
    183 rdf:type schema:DefinedTerm
    184 sg:grant.2516501 http://pending.schema.org/fundedItem sg:pub.10.1038/83241
    185 rdf:type schema:MonetaryGrant
    186 sg:grant.2613508 http://pending.schema.org/fundedItem sg:pub.10.1038/83241
    187 rdf:type schema:MonetaryGrant
    188 sg:journal.1113716 schema:issn 1078-8956
    189 1546-170X
    190 schema:name Nature Medicine
    191 schema:publisher Springer Nature
    192 rdf:type schema:Periodical
    193 sg:person.010261433767.86 schema:affiliation grid-institutes:grid.284589.a
    194 schema:familyName Southan
    195 schema:givenName Garry J.
    196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010261433767.86
    197 rdf:type schema:Person
    198 sg:person.01060330541.04 schema:affiliation grid-institutes:grid.284589.a
    199 schema:familyName Virág
    200 schema:givenName László
    201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01060330541.04
    202 rdf:type schema:Person
    203 sg:person.01174557141.43 schema:affiliation grid-institutes:grid.284589.a
    204 schema:familyName Marton
    205 schema:givenName Anita
    206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174557141.43
    207 rdf:type schema:Person
    208 sg:person.01216344363.14 schema:affiliation grid-institutes:grid.284589.a
    209 schema:familyName Szabó
    210 schema:givenName Éva
    211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216344363.14
    212 rdf:type schema:Person
    213 sg:person.01242743756.91 schema:affiliation grid-institutes:grid.261331.4
    214 schema:familyName Hoyt
    215 schema:givenName Dale G.
    216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01242743756.91
    217 rdf:type schema:Person
    218 sg:person.01271463624.22 schema:affiliation grid-institutes:grid.284589.a
    219 schema:familyName Jagtap
    220 schema:givenName Prakash
    221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271463624.22
    222 rdf:type schema:Person
    223 sg:person.012766442042.28 schema:affiliation grid-institutes:grid.284589.a
    224 schema:familyName Murthy
    225 schema:givenName Kanneganti G. K.
    226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012766442042.28
    227 rdf:type schema:Person
    228 sg:person.015467071427.47 schema:affiliation grid-institutes:grid.284589.a
    229 schema:familyName Mabley
    230 schema:givenName Jon G.
    231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015467071427.47
    232 rdf:type schema:Person
    233 sg:person.0663715027.63 schema:affiliation grid-institutes:grid.430387.b
    234 schema:familyName Szabó
    235 schema:givenName Csaba
    236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663715027.63
    237 rdf:type schema:Person
    238 sg:person.0675766741.07 schema:affiliation grid-institutes:grid.8515.9
    239 schema:familyName Liaudet
    240 schema:givenName Lucas
    241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675766741.07
    242 rdf:type schema:Person
    243 sg:person.0676312677.21 schema:affiliation grid-institutes:grid.284589.a
    244 schema:familyName Salzman
    245 schema:givenName Andrew L.
    246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676312677.21
    247 rdf:type schema:Person
    248 sg:pub.10.1038/34923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004282327
    249 https://doi.org/10.1038/34923
    250 rdf:type schema:CreativeWork
    251 sg:pub.10.1038/35008121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031794389
    252 https://doi.org/10.1038/35008121
    253 rdf:type schema:CreativeWork
    254 sg:pub.10.1038/6535 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006268292
    255 https://doi.org/10.1038/6535
    256 rdf:type schema:CreativeWork
    257 sg:pub.10.1038/nm1097-1089 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052495095
    258 https://doi.org/10.1038/nm1097-1089
    259 rdf:type schema:CreativeWork
    260 grid-institutes:grid.261331.4 schema:alternateName Division of Pharmacology, College of Pharmacy, The Ohio State University, 496 West 12th Avenue, 43210, Columbus, Ohio, USA
    261 schema:name Division of Pharmacology, College of Pharmacy, The Ohio State University, 496 West 12th Avenue, 43210, Columbus, Ohio, USA
    262 rdf:type schema:Organization
    263 grid-institutes:grid.284589.a schema:alternateName Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA
    264 schema:name Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA
    265 rdf:type schema:Organization
    266 grid-institutes:grid.411074.7 schema:alternateName Department of Critical Care Medicine, Hospital das Clinicas da Universidade de Sao Paulo, Sao Paulo, Brazil
    267 schema:name Department of Critical Care Medicine, Hospital das Clinicas da Universidade de Sao Paulo, Sao Paulo, Brazil
    268 Department of Surgery, New Jersey Medical School, University of Medicine and Dentistry New Jersey, 185 University Heights, 01703, Newark, New Jersey, USA
    269 Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA
    270 rdf:type schema:Organization
    271 grid-institutes:grid.430387.b schema:alternateName Department of Surgery, New Jersey Medical School, University of Medicine and Dentistry New Jersey, 185 University Heights, 01703, Newark, New Jersey, USA
    272 schema:name Department of Surgery, New Jersey Medical School, University of Medicine and Dentistry New Jersey, 185 University Heights, 01703, Newark, New Jersey, USA
    273 Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA
    274 rdf:type schema:Organization
    275 grid-institutes:grid.8515.9 schema:alternateName Department of Internal Medicine, Critical Care Division, University Hospital, Lausanne, Switzerland
    276 schema:name Department of Internal Medicine, Critical Care Division, University Hospital, Lausanne, Switzerland
    277 Department of Surgery, New Jersey Medical School, University of Medicine and Dentistry New Jersey, 185 University Heights, 01703, Newark, New Jersey, USA
    278 Inotek Corporation, Suite 419E, 100 Cummings Center, 01915, Beverly, Massachusetts, USA
    279 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...